Mbiya-Mukinayi, Benoît
Kalala-Mushinta, Corneille
Kalombo-Munganga, Schadrac
Kalala-Mwanza, Alexandre
Kasongo-Tshiala, Steve
Mpoyi-Kalenda, John
Gulbis, Béatrice
Article History
Received: 18 October 2024
Accepted: 23 April 2025
First Online: 18 May 2025
Declarations
:
: All parents or legal sponsors of patients provided written informed consent to participate in the study. The study protocol was reviewed and approved by the ethics committee of the Research Centre for Mashi-Sickle Cell Disease and Other Red Blood Cell Diseases (N/Ref: 012/CR/CRM/CPM/YMK/2024). The study was conducted in accordance with the principles of the Declaration of Helsinki II. The purpose and procedures of the study were explained to the participants and legal respondents. The participants were informed that they could withdraw at any time without further obligation and would continue to receive care without prejudice. The anonymity of the participants was guaranteed, and no personal data were recorded.
: Not applicable.
: The authors declare no competing interests.